Announced
Synopsis
Triangle Capital, a specialty finance company, agreed to acquire Bourn Bioscience, a centre for the treatment of infertility. Financial terms were not disclosed. “The Grant Thornton team did a great job and we are thankful for their continued support throughout the process. They really went the extra mile for us, which delivered a great result for the business and the shareholders," Michael Macnamee, Bourn Hall CEO.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.